Table 2.

Summary of key travoprost safety data

Safety event	Incidence in eyes treated with travoprost	References
Conjunctival hyperemia	32.5%–49.5%	Goldberg et al 2001; Netland et al 2001; Fellman et al 2002
Iris hyperpigmentation	1.0%–3.6%	Goldberg et al 2001; Netland et al 2001; Fellman et al 2002
Eyelash changes	51%–76.2%	Goldberg et al 2001; Netland et al 2001, Fellman et al 2002
Periocular hyperpigmentation	Rare	Goldberg et al 2001; Netland et al 2001; Fellman et al 2002
Iritis	Rare	Kumarasamy and Desai 2004
Macular edema	Rare	Del Hierro et al 2004